Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis-Reference-Cited by-同舟云学术

Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis

Published:2003-05 Issue:1 Volume:194 Page:119-124
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Karayiannakis Anastasios J.,Bolanaki Helen,Syrigos Konstantinos N.,Asimakopoulos Byron,Polychronidis Alexandros,Anagnostoulis Stavros,Simopoulos Constantinos

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference29 articles.

1. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis;Dvorak;Am. J. Pathol.,1995

2. The human gene for vascular endothelial growth factor: multiple protein forms are encoded through alternative exon splicing;Tischer;J. Biol. Chem.,1991

3. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA;Houck;Mol. Endocrinol.,1991

4. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer;Itakura;Int. J. Cancer,2000

5. De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop;von Marschall;Gastroenterology,2000

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of VEGF-2549I/D promoter polymorphism with gastrointestinal tract cancer risk: a meta-analysis;Egyptian Journal of Medical Human Genetics;2024-06-17

2. VEGF gene polymorphisms in Iranian patients with intracranial glioblastoma;Journal of Neurosurgical Sciences;2023-01

3. Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers;Frontiers in Oncology;2022-10-10

4. Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation;Evidence-Based Complementary and Alternative Medicine;2022-05-10

5. Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target;Frontiers in Cell and Developmental Biology;2021-11-10